Dorota Dziugiell

Dorota Dziugiell Portfolio

Invests via Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group | Managed by Dorota Dziugiell
Invests via Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group
Managed by Dorota Dziugiell
Automatically Tracked
Tracking: 0 Updated: Jul 22 at 06:06 AM
Dorota Dziugiell Profile

Seasoned investor and operator focused on growth-stage technology and consumer businesses, combining operating experience with active early-stage deal sourcing and board involvement. Dorota Dziugiell is known for driving commercial scaling, go-to-market strategy and cross-border expansion for portfolio companies; profile typically aligns with VC or growth equity roles and independent advisory work. Market-relevant strengths include strategic partnerships, revenue operations and talent recruitment to support rapid revenue inflection and exit readiness.

Seasoned investor and operator focused on growth-stage technology and consumer businesses, combining operating experience with active early-stage deal sourcing and board involvement. Dorota Dziugiell is known for driving commercial scaling, go-to-market strategy and cross-border expansion for portfolio companies; profile typically aligns with VC or growth equity roles and independent advisory work. Market-relevant strengths include strategic partnerships, revenue operations and talent recruitment to support rapid revenue inflection and exit readiness.

Investment Philosophy & Strategy

Focuses on growth-stage tech and consumer opportunities where operator-led value creation accelerates commercial scale. Prioritizes companies with repeatable go-to-market motion, clear unit economics and cross-border expansion potential, deploying growth-equity or active VC capital alongside board-level engagement. Investment decisions hinge on measurable revenue ops levers, strategic partnerships and founding-team recruitability. Time horizon is medium-term growth to liquidity, with disciplined staging of follow-on capital, KPI-driven milestones, and an emphasis on exit readiness through revenue inflection.

Focuses on growth-stage tech and consumer opportunities where operator-led value creation accelerates commercial scale. Prioritizes companies with repeatable go-to-market motion, clear unit economics and cross-border expansion potential, deploying growth-equity or active VC capital alongside board-level engagement. Investment decisions hinge on measurable revenue ops levers, strategic partnerships and founding-team recruitability. Time horizon is medium-term growth to liquidity, with disciplined staging of follow-on capital, KPI-driven milestones, and an emphasis on exit readiness through revenue inflection.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
110.41%
Gain -2.08%
Monthly
1.17%
Yearly
15.03%
Drawdown
27.55%
$351.5M
Equity
Holdings
$351.5M
Investment
$237.55M
$250.78M
Profit -$1.29M
Realized
$131.11M
Unrealized
$119.67M
Dividends
$23.96M

Goals

Avg. 100% completed goals
Yearly
Gain > 5%
2026
100%
Yearly
Gain < 20%
2026
100%
Today
Compared To Yesterday
Gain
-2.08%
Profit
-$1.29M
Win %
76%
This Week
Compared To Last Week
Gain
0.16%
Profit
$542,448.16
Win %
76%
This Month
Compared to last month
Gain
-1.62%
Profit
-$5.77M
Win %
76%
This Year
Compared to last year
Gain
34.1%
Profit
$89.33M
Win %
76%
Micron Technology, Inc. logo
MU Micron Technology, Inc.
+12.17%
+$4.74M
Advanced Micro Devices, Inc. logo
AMD Advanced Micro Devices, Inc.
+8.11%
+$2.48M
C4 Therapeutics Inc. logo
CCCC C4 Therapeutics Inc.
+6.98%
+$21,250
Marvell Technology, Inc. logo
MRVL Marvell Technology, Inc.
+6.68%
+$1.5M
Freeport-McMoRan Inc. logo
FCX Freeport-McMoRan Inc.
+6.37%
+$667,696.05
Pan American Silver Corp. logo
PAAS Pan American Silver Corp.
+5.31%
+$641,372.48
Microchip Technology Incorporated logo
MCHP Microchip Technology Incorporated
+3.56%
+$301,350
Tidewater Inc. logo
TDW Tidewater Inc.
+3.53%
+$25,873.82
Neurocrine Biosciences Inc. logo
NBIX Neurocrine Biosciences Inc.
+3.5%
+$183,920
Nurix Therapeutics Inc. logo
NRIX Nurix Therapeutics Inc.
+3.39%
+$65,450
Arvinas Inc. logo
ARVN Arvinas Inc.
+2.99%
+$13,800
NVIDIA Corporation logo
NVDA NVIDIA Corporation
+1.97%
+$308,769.23
ConocoPhillips logo
COP ConocoPhillips
+1.57%
+$69,160
Syndax Pharmaceuticals Inc. logo
SNDX Syndax Pharmaceuticals Inc.
+1.57%
+$70,000
Logitech International S.A. logo
LOGI Logitech International S.A.
+1.11%
+$42,438.28
Stellantis N.V. logo
STLA Stellantis N.V.
+0.52%
+$12,000
Apple Inc. logo
AAPL Apple Inc.
+0.35%
+$63,249.45
ServiceNow, Inc. logo
NOW ServiceNow, Inc.
0%
$0
Snowflake Inc. logo
SNOW Snowflake Inc.
0%
$0
MSCI Inc. logo
MSCI MSCI Inc.
-10.14%
-$707,842.9
Salesforce Inc logo
CRM Salesforce Inc
-2.15%
-$193,959.48
Alphabet Inc logo
GOOGL Alphabet Inc
-1.37%
-$317,213.6
Microsoft Corp. logo
MSFT Microsoft Corp.
-1.13%
-$347,310.77
Amazon.com Inc logo
AMZN Amazon.com Inc
-0.98%
-$226,920.93
Deckers Outdoor Corporation logo
DECK Deckers Outdoor Corporation
-0.7%
-$86,220.42
MercadoLibre, Inc. logo
MELI MercadoLibre, Inc.
-0.53%
-$51,585.71
DoorDash, Inc. logo
DASH DoorDash, Inc.
-0.52%
-$49,108
Paymentus Holdings Inc. logo
PAY Paymentus Holdings Inc.
-0.17%
-$36,673.5
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
1489
Longs Won
937/1489 62%
Profit Factor
3.5
Profitability
Shorts Won
0/0 0%
Standard Deviation
$1.2M
Average Win
$374,537.69
Best Trade
(Jul 22) $21.67M
Sharpe Ratio
-8.46
Average Loss
-$181,449.84
Worst Trade
(Jun 29) -$5.73M
Z-Score
-2.85 (100%)
Commissions
$0
Avg. Trade Length
1y 3m 2w 6d
Expectancy
$168,422.77
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.02%
Consecutive Losing Trades 1,938 1,744 1,550 1,357 1,163 969 775 581 388 194
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Dorota Dziugiell?
The largest contributions to the portfolio's profits come from the following stocks: NVIDIA Corporation - $23.45M, PayPal Holdings Inc - $15.3M, Meta Platforms Inc Class A - $9.25M, Alphabet Inc - $8.97M, and Micron Technology, Inc - $8.14M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: KORS - $5.73M, Enphase Energy, Inc - $4.41M, FIT - $3.01M, Dine Brands Global Inc - $2.81M, and Mosaic Company - $2.74M. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Dorota Dziugiell's portfolio generate?
The portfolio generates substantial dividend income, with a total of $23.96M earned over time. The largest contributors to dividend income include General Electric Company - $1.59M, Bank of America Corporation - $738,627.6, Lowe's Companies Inc - $736,734.28, Wells Fargo & Company - $678,089, and Mosaic Company - $656,250. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Dorota Dziugiell's monthly returns?
Dorota Dziugiell's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can Dorota Dziugiell's strategy be considered aggressive or moderate?
Dorota Dziugiell's strategy appears moderately aggressive. The portfolio shows a clear focus on growth, with noticeable volatility and risk exposure, although not to an extreme level. This type of strategy may appeal to users seeking higher returns while accepting meaningful fluctuations along the way.
Should beginners follow Dorota Dziugiell's strategy?
Dorota Dziugiell's strategy is probably not ideal for beginners. The combination of risk, volatility, or portfolio complexity may make it harder to follow and understand without prior experience. Users who are new to investing may find it challenging to replicate or tolerate the performance swings.
Account USV